Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF
Abstract Introduction Familial Mediterranean Fever (FMF) is the most common monogentic autoinflammatory disease. FMF results from mutations in MEFV, which lead to a pro-inflammatory state and increased production of Interleukin 1 beta subunit (IL-1b) by myeloid cells. Despite the overall positive re...
Saved in:
Main Authors: | Shiran Pinchevski-Kadir (Author), Maya Gerstein (Author), Oren Pleniceanu (Author), Yonatan Yacobi (Author), Asaf Vivante (Author), Ortal Erez Granat (Author), Shiri Spielman (Author), Rotem Semo Oz (Author), Irit Tirosh (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients
by: Keren Cohen, et al.
Published: (2023) -
Arthritis in children with LRBA deficiency - case report and literature review
by: Rotem Semo Oz, et al.
Published: (2019) -
Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
by: Reiff AO, et al.
Published: (2011) -
Awareness of FMF among Caregivers
by: Belde Kasap Demir, et al.
Published: (2021) -
TRMT10A Mutation in a Child with Diabetes, Short Stature, Microcephaly and Hypoplastic Kidneys
by: Eve Stern, et al.
Published: (2022)